Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,601-6,612 of 10,592
Drug study icon
WithdrawnNCT04054973

L-arginine Study for Persistent Symptoms of Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
Drug study icon
CompletedNCT00177463

L-Carnosine for Bipolarity type I

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Drug study icon
CompletedNCT00177177

L-carnosine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Drug study icon
CompletedNCT01853280

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT02558790

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT00799409

Lab School Day Study for CONCERTA of Older Children With ADHD

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 9 Years to 12 Years
Countries
United States
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Condition
ADHD
Behavioral study icon
Active Not RecruitingNCT06992791

Labor Education to Reduce Postpartum Traumatic Stress

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralFrom 18 Years to 51 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
PTSD
Drug study icon
TerminatedNCT04396847

Laboratory Screening of Lorcaserin for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
The Mind Research Network
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.